Skip to main content
Erschienen in: Current Cardiology Reports 6/2019

01.06.2019 | Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Treatment Challenges in Patients with Acute Heart Failure and Severe Aortic Valve Stenosis

verfasst von: Tobias Schmidt, Christian Frerker

Erschienen in: Current Cardiology Reports | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The goal of this paper is to describe the treatment challenges in patients with aortic stenosis in combination with a reduced left ventricular function.

Recent Findings

Since the risk of mortality is increased in this patient population, transcatheter aortic valve implantation emerged as an important treatment option. Concomitant factors such as mitral regurgitation or coronary artery disease are important co-factors that need to be evaluated and taken into account for treatment decision.

Summary

Treatment of the severe aortic stenosis is key in this complex setting. Since several co-factors may exist in addition to aortic stenosis, treatment needs to be decided by a Heart Team.
Literatur
1.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno HC, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129–200. Ponikowski P, Voors AA, Anker SD, Bueno HC, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129–200.
2.
Zurück zum Zitat Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014;2(2):97–112.PubMedPubMedCentral Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, et al. Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail. 2014;2(2):97–112.PubMedPubMedCentral
3.
Zurück zum Zitat • Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38(45):3351–8. This study is important in this context, since it explains the progression of aortic stenosis and cardiac damage if left untreated. PubMedPubMedCentral • Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38(45):3351–8. This study is important in this context, since it explains the progression of aortic stenosis and cardiac damage if left untreated. PubMedPubMedCentral
4.
Zurück zum Zitat Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(3):254–75. Baumgartner HC, Hung JC-C, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, et al. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2017;18(3):254–75.
5.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;10:893–53. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;10:893–53.
6.
Zurück zum Zitat Monin J-L, Quere J-P, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108(3):319–24.PubMed Monin J-L, Quere J-P, Monchi M, Petit H, Baleynaud S, Chauvel C, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation. 2003;108(3):319–24.PubMed
7.
Zurück zum Zitat Levy F, Laurent M, Monin J-L, Maillet JM, Pasquet A, Le Tourneau T, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51(15):1466–72.PubMed Levy F, Laurent M, Monin J-L, Maillet JM, Pasquet A, Le Tourneau T, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study. J Am Coll Cardiol. 2008;51(15):1466–72.PubMed
8.
Zurück zum Zitat Clavel M-A, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–13.PubMedPubMedCentral Clavel M-A, Pibarot P, Messika-Zeitoun D, Capoulade R, Malouf J, Aggarval S, et al. Impact of aortic valve calcification, as measured by MDCT, on survival in patients with aortic stenosis: results of an international registry study. J Am Coll Cardiol. 2014;64(12):1202–13.PubMedPubMedCentral
9.
Zurück zum Zitat Clavel M-A, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62(24):2329–38.PubMed Clavel M-A, Messika-Zeitoun D, Pibarot P, Aggarwal SR, Malouf J, Araoz PA, et al. The complex nature of discordant severe calcified aortic valve disease grading: new insights from combined Doppler echocardiographic and computed tomographic study. J Am Coll Cardiol. 2013;62(24):2329–38.PubMed
10.
Zurück zum Zitat Cueff C, Serfaty J-M, Cimadevilla C, Laissy J-P, Himbert D, Tubach F, et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart. 2011;97(9):721–6.PubMed Cueff C, Serfaty J-M, Cimadevilla C, Laissy J-P, Himbert D, Tubach F, et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart. 2011;97(9):721–6.PubMed
11.
Zurück zum Zitat Ito S, Miranda WR, Nkomo VT, Connolly HM, Pislaru SV, Greason KL, et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol. 2018;71(12):1313–21.PubMed Ito S, Miranda WR, Nkomo VT, Connolly HM, Pislaru SV, Greason KL, et al. Reduced left ventricular ejection fraction in patients with aortic stenosis. J Am Coll Cardiol. 2018;71(12):1313–21.PubMed
12.
Zurück zum Zitat Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.PubMed Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med. 2008;359(13):1343–56.PubMed
13.
Zurück zum Zitat Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012;19(4):403–88.PubMed Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Int J Behav Med. 2012;19(4):403–88.PubMed
14.
Zurück zum Zitat Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.PubMed Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.PubMed
15.
Zurück zum Zitat Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI Registry. J Am Coll Cardiol. 2018;71(12):1297–308.PubMed Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, et al. Transcatheter aortic valve replacement in patients with low-flow, low-gradient aortic stenosis: the TOPAS-TAVI Registry. J Am Coll Cardiol. 2018;71(12):1297–308.PubMed
16.
Zurück zum Zitat Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.PubMed Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.PubMed
17.
Zurück zum Zitat Brennan JM, Thomas L, Cohen DJ, Shahian D, Wang A, Mack MJ, et al. Transcatheter versus surgical aortic valve replacement: propensity-matched comparison. J Am Coll Cardiol. 2017;70(4):439–50.PubMedPubMedCentral Brennan JM, Thomas L, Cohen DJ, Shahian D, Wang A, Mack MJ, et al. Transcatheter versus surgical aortic valve replacement: propensity-matched comparison. J Am Coll Cardiol. 2017;70(4):439–50.PubMedPubMedCentral
18.
Zurück zum Zitat Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, et al. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 2013;6(6):604–14.PubMed Elmariah S, Palacios IF, McAndrew T, Hueter I, Inglessis I, Baker JN, et al. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv. 2013;6(6):604–14.PubMed
19.
Zurück zum Zitat Brown JM, O’Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82–90.PubMed Brown JM, O’Brien SM, Wu C, Sikora JAH, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82–90.PubMed
20.
Zurück zum Zitat Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36(4):1152–8.PubMed Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000;36(4):1152–8.PubMed
21.
Zurück zum Zitat Holzhey D, Mohr FW, Walther T, Mollmann H, Beckmann A, Kötting J, et al. Current results of surgical aortic valve replacement: insights from the German Aortic Valve Registry. Ann Thorac Surg. 2016;101(2):658–66.PubMed Holzhey D, Mohr FW, Walther T, Mollmann H, Beckmann A, Kötting J, et al. Current results of surgical aortic valve replacement: insights from the German Aortic Valve Registry. Ann Thorac Surg. 2016;101(2):658–66.PubMed
22.
Zurück zum Zitat Biancari F, Martin M, Bordin G, Vettore E, Vinco G, Anttila V, et al. Basic data from 176 studies on the immediate outcome after aortic valve replacement with or without coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2014;28(5):1251–6.PubMed Biancari F, Martin M, Bordin G, Vettore E, Vinco G, Anttila V, et al. Basic data from 176 studies on the immediate outcome after aortic valve replacement with or without coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2014;28(5):1251–6.PubMed
23.
Zurück zum Zitat Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013;127(16):1647–55.PubMed Brennan JM, Edwards FH, Zhao Y, O’Brien S, Booth ME, Dokholyan RS, et al. Long-term safety and effectiveness of mechanical versus biologic aortic valve prostheses in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database. Circulation. 2013;127(16):1647–55.PubMed
24.
Zurück zum Zitat Langanay T, Rouze S, Tomasi J, Aymami M, Rehman SM, Anselmi A, et al. Conventional aortic valve replacement in 2005 elderly patients: a 32-year experience. Eur J Cardiothorac Surg. 2018;54:446–52.PubMed Langanay T, Rouze S, Tomasi J, Aymami M, Rehman SM, Anselmi A, et al. Conventional aortic valve replacement in 2005 elderly patients: a 32-year experience. Eur J Cardiothorac Surg. 2018;54:446–52.PubMed
25.
Zurück zum Zitat David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 2001;121(2):268–77.PubMed David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G. Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg. 2001;121(2):268–77.PubMed
26.
Zurück zum Zitat Forcillo J, Pellerin M, Perrault LP, Cartier R, Bouchard D, Demers P, et al. Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg. 2013;96(2):486–93.PubMed Forcillo J, Pellerin M, Perrault LP, Cartier R, Bouchard D, Demers P, et al. Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg. 2013;96(2):486–93.PubMed
27.
Zurück zum Zitat Mohty D, Magne J, Deltreuil M, Aboyans V, Echahidi N, Cassat C, et al. Outcome and impact of surgery in paradoxical low-flow, low-gradient severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study. Circulation. 2013;128(11 Suppl 1):S235–42.PubMed Mohty D, Magne J, Deltreuil M, Aboyans V, Echahidi N, Cassat C, et al. Outcome and impact of surgery in paradoxical low-flow, low-gradient severe aortic stenosis and preserved left ventricular ejection fraction: a cardiac catheterization study. Circulation. 2013;128(11 Suppl 1):S235–42.PubMed
28.
Zurück zum Zitat Parikh R, Goodman AL, Barr T, Sabik JF, Svensson LG, Rodriguez LL, et al. Outcomes of surgical aortic valve replacement for severe aortic stenosis: incorporation of left ventricular systolic function and stroke volume index. J Thorac Cardiovasc Surg. 2015;149(6):1558–66.e1.PubMed Parikh R, Goodman AL, Barr T, Sabik JF, Svensson LG, Rodriguez LL, et al. Outcomes of surgical aortic valve replacement for severe aortic stenosis: incorporation of left ventricular systolic function and stroke volume index. J Thorac Cardiovasc Surg. 2015;149(6):1558–66.e1.PubMed
29.
Zurück zum Zitat Dahl JS, Eleid MF, Michelena HI, Scott CG, Suri RM, Schaff HV, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8(4):e002917.PubMed Dahl JS, Eleid MF, Michelena HI, Scott CG, Suri RM, Schaff HV, et al. Effect of left ventricular ejection fraction on postoperative outcome in patients with severe aortic stenosis undergoing aortic valve replacement. Circ Cardiovasc Imaging. 2015;8(4):e002917.PubMed
30.
Zurück zum Zitat Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.PubMed Iung B, Cachier A, Baron G, Messika-Zeitoun D, Delahaye F, Tornos P, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.PubMed
31.
Zurück zum Zitat Salas MJ, Santana O, Escolar E, Lamas GA. Medical therapy for calcific aortic stenosis. J Cardiovasc Pharmacol Ther. 2012;17(2):133–8.PubMed Salas MJ, Santana O, Escolar E, Lamas GA. Medical therapy for calcific aortic stenosis. J Cardiovasc Pharmacol Ther. 2012;17(2):133–8.PubMed
32.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.
33.
Zurück zum Zitat Thyregod HGH, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015;65(20):2184–94.PubMed Thyregod HGH, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial. J Am Coll Cardiol. 2015;65(20):2184–94.PubMed
34.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.PubMed Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.PubMed
35.
Zurück zum Zitat Reardon M. A randomized comparison of self-expanding transcatheter and surgical aortic valve replacement in patients with severe aortic stenosis deemed at increased risk for surgery 2-year outcomes. San Diege; 2015. pp. 1–30. Reardon M. A randomized comparison of self-expanding transcatheter and surgical aortic valve replacement in patients with severe aortic stenosis deemed at increased risk for surgery 2-year outcomes. San Diege; 2015. pp. 1–30.
36.
Zurück zum Zitat Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–63.PubMedPubMedCentral Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–63.PubMedPubMedCentral
37.
Zurück zum Zitat Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35(7):455–69.PubMed Damman K, Valente MAE, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35(7):455–69.PubMed
38.
Zurück zum Zitat Voigtlander L, Schewel J, Martin J, Schewel D, Frerker C, Wohlmuth P, et al. Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J Cardiol. 2015;178:275–81.PubMed Voigtlander L, Schewel J, Martin J, Schewel D, Frerker C, Wohlmuth P, et al. Impact of kidney function on mortality after transcatheter valve implantation in patients with severe aortic valvular stenosis. Int J Cardiol. 2015;178:275–81.PubMed
39.
Zurück zum Zitat Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J. 2014;35(7):416–8.PubMed Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J. 2014;35(7):416–8.PubMed
40.
Zurück zum Zitat Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1(8472):63–7.PubMed Cribier A, Savin T, Saoudi N, Rocha P, Berland J, Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1(8472):63–7.PubMed
41.
Zurück zum Zitat Cribier A, Remadi F, Koning R, Rath P, Stix G, Letac B. Emergency balloon valvuloplasty as initial treatment of patients with aortic stenosis and cardiogenic shock. N Engl J Med. 1992;326(9):646.PubMed Cribier A, Remadi F, Koning R, Rath P, Stix G, Letac B. Emergency balloon valvuloplasty as initial treatment of patients with aortic stenosis and cardiogenic shock. N Engl J Med. 1992;326(9):646.PubMed
42.
Zurück zum Zitat Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018;14(5):e519–25.PubMed Debry N, Kone P, Vincent F, Lemesle G, Delhaye C, Schurtz G, et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018;14(5):e519–25.PubMed
43.
Zurück zum Zitat Saia F, Marrozzini C, Ciuca C, Guastaroba P, Taglieri N, Palmerini T, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013;8(12):1388–97.PubMed Saia F, Marrozzini C, Ciuca C, Guastaroba P, Taglieri N, Palmerini T, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013;8(12):1388–97.PubMed
44.
Zurück zum Zitat D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Kukucka M, et al. Transapical transcatheter aortic valve replacement in patients with cardiogenic shock. Interact Cardiovasc Thorac Surg. 2012;14(4):426–30.PubMedPubMedCentral D’Ancona G, Pasic M, Buz S, Drews T, Dreysse S, Kukucka M, et al. Transapical transcatheter aortic valve replacement in patients with cardiogenic shock. Interact Cardiovasc Thorac Surg. 2012;14(4):426–30.PubMedPubMedCentral
45.
Zurück zum Zitat Takagi H, Umemoto T. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016;221:46–51.PubMed Takagi H, Umemoto T. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016;221:46–51.PubMed
46.
Zurück zum Zitat Iung B. Interface between valve disease and ischaemic heart disease. HeartBMJ Publishing Group. 2000;84(3):347–52.PubMedPubMedCentral Iung B. Interface between valve disease and ischaemic heart disease. HeartBMJ Publishing Group. 2000;84(3):347–52.PubMedPubMedCentral
47.
Zurück zum Zitat Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–4.PubMed Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29(3):630–4.PubMed
48.
Zurück zum Zitat Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, et al. Cardiac surgery in Germany during 2009. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2010;58(7):379–86.PubMed Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K, Ernst M, et al. Cardiac surgery in Germany during 2009. A report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. 2010;58(7):379–86.PubMed
49.
Zurück zum Zitat Bridgewater B, Hickey GL, Cooper G, Deanfield J, Roxburgh J. Publishing cardiac surgery mortality rates: lessons for other specialties. BMJ. 2013;346:f1139.PubMed Bridgewater B, Hickey GL, Cooper G, Deanfield J, Roxburgh J. Publishing cardiac surgery mortality rates: lessons for other specialties. BMJ. 2013;346:f1139.PubMed
50.
Zurück zum Zitat Abramowitz Y, Banai S, Katz G, Steinvil A, Arbel Y, Havakuk O, et al. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease. Catheter Cardiovasc Interv. 2014;83(4):649–54.PubMed Abramowitz Y, Banai S, Katz G, Steinvil A, Arbel Y, Havakuk O, et al. Comparison of early and late outcomes of TAVI alone compared to TAVI plus PCI in aortic stenosis patients with and without coronary artery disease. Catheter Cardiovasc Interv. 2014;83(4):649–54.PubMed
51.
Zurück zum Zitat O’Sullivan CJ, Stefanini GG, Stortecky S, Tuller D, Windecker S, Wenaweser P. Coronary revascularization and TAVI: before, during, after or never? Minerva Med. 2014;105(6):475–85.PubMed O’Sullivan CJ, Stefanini GG, Stortecky S, Tuller D, Windecker S, Wenaweser P. Coronary revascularization and TAVI: before, during, after or never? Minerva Med. 2014;105(6):475–85.PubMed
52.
Zurück zum Zitat Van Mieghem NM, van der Boon RM, Faqiri E, Diletti R, Schultz C, van Geuns R-J, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv. 2013;6(8):867–75.PubMed Van Mieghem NM, van der Boon RM, Faqiri E, Diletti R, Schultz C, van Geuns R-J, et al. Complete revascularization is not a prerequisite for success in current transcatheter aortic valve implantation practice. JACC Cardiovasc Interv. 2013;6(8):867–75.PubMed
53.
Zurück zum Zitat D’Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, et al. Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and 1-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14:e1169–77.PubMed D’Ascenzo F, Verardi R, Visconti M, Conrotto F, Scacciatella P, Dziewierz A, et al. Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and 1-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14:e1169–77.PubMed
54.
Zurück zum Zitat Barbanti M, Buccheri S, Capodanno D, D’Errigo P, Ranucci M, Rosato S, et al. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: a comparative analysis from the Italian OBSERVANT study. Int J Cardiol. 2018;270:102–6.PubMed Barbanti M, Buccheri S, Capodanno D, D’Errigo P, Ranucci M, Rosato S, et al. Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: a comparative analysis from the Italian OBSERVANT study. Int J Cardiol. 2018;270:102–6.PubMed
55.
Zurück zum Zitat Allali A, El-Mawardy M, Schwarz B, Sato T, Geist V, Toelg R, et al. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. Cardiovasc Revasc Med. 2016;17(6):391–8.PubMed Allali A, El-Mawardy M, Schwarz B, Sato T, Geist V, Toelg R, et al. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience. Cardiovasc Revasc Med. 2016;17(6):391–8.PubMed
56.
Zurück zum Zitat Blumenstein J, Kim W-K, Liebetrau C, Gaede L, Kempfert J, Walther T, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015;104(8):632–9.PubMed Blumenstein J, Kim W-K, Liebetrau C, Gaede L, Kempfert J, Walther T, et al. Challenges of coronary angiography and intervention in patients previously treated by TAVI. Clin Res Cardiol. 2015;104(8):632–9.PubMed
57.
Zurück zum Zitat Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995;25(2):305–10.PubMed Brener SJ, Duffy CI, Thomas JD, Stewart WJ. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995;25(2):305–10.PubMed
58.
Zurück zum Zitat Moazami N, Diodato MD, Moon MR, Lawton JS, Pasque MK, Herren RL, et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg. 2004;19(5):444–8.PubMed Moazami N, Diodato MD, Moon MR, Lawton JS, Pasque MK, Herren RL, et al. Does functional mitral regurgitation improve with isolated aortic valve replacement? J Card Surg. 2004;19(5):444–8.PubMed
59.
Zurück zum Zitat Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev CardiolNature Publishing Group. 2011;8(3):162–72.PubMed Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev CardiolNature Publishing Group. 2011;8(3):162–72.PubMed
60.
Zurück zum Zitat Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochellière R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63(24):2643–58.PubMed Nombela-Franco L, Ribeiro HB, Urena M, Allende R, Amat-Santos I, DeLarochellière R, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014;63(24):2643–58.PubMed
61.
Zurück zum Zitat Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon MB, Trillo-Nouche R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015;101(17):1395–405.PubMed Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon MB, Trillo-Nouche R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015;101(17):1395–405.PubMed
62.
Zurück zum Zitat Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.PubMed Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.PubMed
63.
Zurück zum Zitat Barreiro CJ, Patel ND, Fitton TP, Williams JA, Bonde PN, Chan V, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation. 2005;112(9 Suppl):I443–7.PubMed Barreiro CJ, Patel ND, Fitton TP, Williams JA, Bonde PN, Chan V, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation. 2005;112(9 Suppl):I443–7.PubMed
64.
Zurück zum Zitat D’Agostino RS, Jacobs JP, Badhwar V, Paone G, Rankin JS, Han JM, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2016 update on outcomes and quality. Ann Thorac Surg. 2016;101(1):24–32.PubMed D’Agostino RS, Jacobs JP, Badhwar V, Paone G, Rankin JS, Han JM, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2016 update on outcomes and quality. Ann Thorac Surg. 2016;101(1):24–32.PubMed
65.
Zurück zum Zitat Mueller XM, Tevaearai HT, Stumpe F, Fischer AP, Hurni M, Ruchat P, et al. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg. 1998;115(6):1298–309.PubMed Mueller XM, Tevaearai HT, Stumpe F, Fischer AP, Hurni M, Ruchat P, et al. Long-term results of mitral-aortic valve operations. J Thorac Cardiovasc Surg. 1998;115(6):1298–309.PubMed
66.
Zurück zum Zitat Harris KM, Malenka DJ, Haney MF, Jayne JE, Hettleman B, Plehn JF, et al. Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol. 1997;80(6):741–5.PubMed Harris KM, Malenka DJ, Haney MF, Jayne JE, Hettleman B, Plehn JF, et al. Improvement in mitral regurgitation after aortic valve replacement. Am J Cardiol. 1997;80(6):741–5.PubMed
67.
Zurück zum Zitat Coutinho GF, Correia PM, Pancas R, Antunes MJ. Management of moderate secondary mitral regurgitation at the time of aortic valve surgery. Eur J Cardiothorac Surg. 2013;44(1):32–40.PubMed Coutinho GF, Correia PM, Pancas R, Antunes MJ. Management of moderate secondary mitral regurgitation at the time of aortic valve surgery. Eur J Cardiothorac Surg. 2013;44(1):32–40.PubMed
68.
Zurück zum Zitat Tunick PA, Gindea A, Kronzon I. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Am J Cardiol. 1990;65(18):1219–21.PubMed Tunick PA, Gindea A, Kronzon I. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation. Am J Cardiol. 1990;65(18):1219–21.PubMed
69.
Zurück zum Zitat Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94.PubMed Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373(9672):1382–94.PubMed
70.
Zurück zum Zitat Brasch AV, Khan SS, DeRobertis MA, Kong JHK, Chiu J, Siegel RJ. Change in mitral regurgitation severity after aortic valve replacement for aortic stenosis. Am J Cardiol. 2000;85(10):1271–4.PubMed Brasch AV, Khan SS, DeRobertis MA, Kong JHK, Chiu J, Siegel RJ. Change in mitral regurgitation severity after aortic valve replacement for aortic stenosis. Am J Cardiol. 2000;85(10):1271–4.PubMed
71.
Zurück zum Zitat Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart. 2011;97(4):272–7.PubMed Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart. 2011;97(4):272–7.PubMed
72.
Zurück zum Zitat Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114(1 Suppl):I541–6.PubMed Ruel M, Kapila V, Price J, Kulik A, Burwash IG, Mesana TG. Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement. Circulation. 2006;114(1 Suppl):I541–6.PubMed
73.
Zurück zum Zitat Barbanti M, Webb JG, Hahn RT, Feldman T, Boone RH, Smith CR, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013;128(25):2776–84.PubMed Barbanti M, Webb JG, Hahn RT, Feldman T, Boone RH, Smith CR, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013;128(25):2776–84.PubMed
74.
Zurück zum Zitat Dumont C, Galli E, Oger E, Fournet M, Flecher E, Leclercq C, et al. Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter. Eur Heart J Cardiovasc Imaging. 2018;19(3):319–28.PubMed Dumont C, Galli E, Oger E, Fournet M, Flecher E, Leclercq C, et al. Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter. Eur Heart J Cardiovasc Imaging. 2018;19(3):319–28.PubMed
75.
Zurück zum Zitat Dahou A, Magne J, Clavel M-A, Capoulade R, Bartko PE, Bergler-Klein J, et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis). JACC Cardiovasc Interv. 2015;8(4):588–96.PubMed Dahou A, Magne J, Clavel M-A, Capoulade R, Bartko PE, Bergler-Klein J, et al. Tricuspid regurgitation is associated with increased risk of mortality in patients with low-flow low-gradient aortic stenosis and reduced ejection fraction: results of the multicenter TOPAS study (True or Pseudo-Severe Aortic Stenosis). JACC Cardiovasc Interv. 2015;8(4):588–96.PubMed
76.
Zurück zum Zitat Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, Suri RM, et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e002073. https://doi.org/10.1161/CIRCINTERVENTIONS.114.002073. Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, Suri RM, et al. Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circ Cardiovasc Interv. 2015 Apr;8(4). pii: e002073. https://​doi.​org/​10.​1161/​CIRCINTERVENTION​S.​114.​002073.
77.
Zurück zum Zitat Antunes MJ, Rodriguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, et al. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg. 2017;52(6):1022–30.PubMed Antunes MJ, Rodriguez-Palomares J, Prendergast B, De Bonis M, Rosenhek R, Al-Attar N, et al. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of Cardiovascular Surgery and Valvular Heart Disease. Eur J Cardiothorac Surg. 2017;52(6):1022–30.PubMed
78.
Zurück zum Zitat Sakata T, Mogi K, Sakurai M, Nomura A, Fujii M, Kaneyuki D, et al. Effect of tricuspid annuloplasty concomitant with left heart surgery on right heart geometry and function. J Thorac Cardiovasc Surg. 2018;156(3):1050–61.PubMed Sakata T, Mogi K, Sakurai M, Nomura A, Fujii M, Kaneyuki D, et al. Effect of tricuspid annuloplasty concomitant with left heart surgery on right heart geometry and function. J Thorac Cardiovasc Surg. 2018;156(3):1050–61.PubMed
79.
Zurück zum Zitat Ando T, Takagi H, Briasoulis A, Telila T, Slovut DP, Afonso L, et al. A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions. Catheter Cardiovasc Interv. 2018;91(1):124–34.PubMed Ando T, Takagi H, Briasoulis A, Telila T, Slovut DP, Afonso L, et al. A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions. Catheter Cardiovasc Interv. 2018;91(1):124–34.PubMed
80.
Zurück zum Zitat Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99(16):1185–91.PubMedPubMedCentral Fairbairn TA, Steadman CD, Mather AN, Motwani M, Blackman DJ, Plein S, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study. Heart. 2013;99(16):1185–91.PubMedPubMedCentral
81.
Zurück zum Zitat Onorati F, D’Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, et al. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg. 2014;147(2):568–75.PubMed Onorati F, D’Errigo P, Grossi C, Barbanti M, Ranucci M, Covello DR, et al. Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: results from a propensity-matched population of the Italian OBSERVANT multicenter study. J Thorac Cardiovasc Surg. 2014;147(2):568–75.PubMed
82.
Zurück zum Zitat Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, et al. Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80–8.PubMed Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, et al. Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80–8.PubMed
83.
Zurück zum Zitat Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJJ. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980;62(1):42–8.PubMed Carabello BA, Green LH, Grossman W, Cohn LH, Koster JK, Collins JJJ. Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation. 1980;62(1):42–8.PubMed
84.
Zurück zum Zitat •• Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, et al. Acute heart failure in patients with severe aortic stenosis- insights from the CURRENT AS Registry. Circ J. 2018;82(3):874–85. This study is of major importance since it shows the complication of acute heart failure in patients with severe AS. Careful management to avoid the development of acute heart failure in these patients is crucial. PubMed •• Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, et al. Acute heart failure in patients with severe aortic stenosis- insights from the CURRENT AS Registry. Circ J. 2018;82(3):874–85. This study is of major importance since it shows the complication of acute heart failure in patients with severe AS. Careful management to avoid the development of acute heart failure in these patients is crucial. PubMed
85.
Zurück zum Zitat • Frerker C, Schewel J, Schluter M, Schewel D, Ramadan H, Schmidt T, et al. Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroIntervention. 2016;11(13):1530–6. This study is important since it describes the treatment in patients with aortic stenosis in an end-stage of decompensation (the cardiogenic shock). PubMed • Frerker C, Schewel J, Schluter M, Schewel D, Ramadan H, Schmidt T, et al. Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroIntervention. 2016;11(13):1530–6. This study is important since it describes the treatment in patients with aortic stenosis in an end-stage of decompensation (the cardiogenic shock). PubMed
86.
Zurück zum Zitat Landes U, Orvin K, Codner P, Assali A, Vaknin-Assa H, Schwartznberg S, et al. Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure: procedural and 30-day outcomes. Can J Cardiol. 2016;32(6):726–31.PubMed Landes U, Orvin K, Codner P, Assali A, Vaknin-Assa H, Schwartznberg S, et al. Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure: procedural and 30-day outcomes. Can J Cardiol. 2016;32(6):726–31.PubMed
Metadaten
Titel
Treatment Challenges in Patients with Acute Heart Failure and Severe Aortic Valve Stenosis
verfasst von
Tobias Schmidt
Christian Frerker
Publikationsdatum
01.06.2019
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 6/2019
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-019-1135-7

Weitere Artikel der Ausgabe 6/2019

Current Cardiology Reports 6/2019 Zur Ausgabe

Structural Heart Disease (RJ Siegel and NC Wunderlich, Section Editors)

Transseptal Puncture: Devices, Techniques, and Considerations for Specific Interventions

Ischemic Heart Disease (D Mukherjee, Section Editor)

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

Is There a Need to Revise Goals in the Management of Dyslipidemias?

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Psychosocial Factors and Recovery After Acute Myocardial Infarction in Younger Women

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.